Low Evidence
Research Overview
LL-37 Research for Antimicrobial Resistance
An evidence-based overview of research examining LL-37 in the context of antimicrobial resistance. This page synthesizes findings from peer-reviewed literature.
Research Summary
Laboratory antimicrobial activity motivates drug-development research, but the cited trials do not demonstrate that native LL-37 treats resistant infections or prevents resistance in people. Other antimicrobial peptide drugs and mimetics cannot be counted as LL-37 trials.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Always consult a healthcare provider before making health decisions.